Cor Vasa 2025, 67(4):511-534 | DOI: 10.33678/cor.2025.084
Genetické vyšetření v kardiologii: Aktualizované souhrnné vyjádření a doporučení odborníků pracovní skupiny kardiogenetiky při ČAPK/ČKS, SLG a ČSSL a ST při ČSL JEP
- a Centrum dědičných kardiovaskulárních onemocnění, Klinika kardiologie, Institut klinické a experimentální medicíny, Praha, Česká republika, ERN GUARD Heart
- b Ústav biologie a lékařské genetiky, 2. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice v Motole, Praha, Česká republika, ERN ITHACA
- c Dětské kardiocentrum, 2. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice v Motole, Praha, Česká republika, ERN GUARD Heart
- d Klinika dětí a dorostu, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice v Praze, Praha, Česká republika
- e Ústav soudního lékařství, Lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Hradec Králové, Hradec Králové, Česká republika
- f I. interní kardioangiologická klinika, Fakultní nemocnice u sv. Anny, Brno a Centrum prenatální diagnostiky Brno, Brno, Česká republika
- g Ústav klinické a molekulární patologie a lékařské genetiky, Fakultní nemocnice Ostrava, Ostrava, Česká republika
- h Centrum kardiovaskulární a transplantační chirurgie Brno, Brno, Česká republika
- ch Klinika kardiovaskulární a transplantační chirurgie, Lékařská fakulta Masarykovy univerzity Brno, Brno, Česká republika
- i Ústav klinické imunologie a alergologie, Lékařská fakulta Masarykovy univerzity Brno, Brno, Česká republika
- j Interní kardiologická klinika, Fakultní nemocnice Brno a Lékařská fakulta Masarykovy univerzity Brno, Brno, Česká republika
- k Kardiologická klinika, 2. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice v Motole, Praha, Česká republika, ERN GUARD-Heart
In contemporary cardiology, genetics is mainly applied to cardiovascular diseases with Mendelian inheritance. These diseases include cardiomyopathies, hereditary forms of arrhythmic syndromes, aortic syndromes, congenital heart defects, and hyperlipoproteinemias. Complex testing in cardiogenetics includes family cascade screening, which should be performed in conjunction with molecular genetic testing and contributes to the identifi cation of pathogenic DNA variants. Sudden cardiac death is a common risk for all of these disease groups; therefore, postmortem genetic testing (molecular autopsy) is an important part of cardiogenetics and includes examination of relatives. Knowledge of the molecular basis of genetic diseases opens up the possibility of personalized care. Cardiogenetic testing is a matter for interdisciplinary teams of cardiologists, geneticists, autopsy performing physicians, neurologists, lipidologists, angiologists, and other professions. Communication between the different professionals and teams, both locally and nationally, is essential to ensure quality and standardised care for patients with inherited cardiovascular diseases. Recent recommendations from the European Societies for Cardiology and for Human Genetics (ESC and ESHG) have re-adjusted some of the procedures, so we now provide an update for Czech professionals.
Keywords: Cardiac arrest Cardiomyopathy Familiar hypercholesterolemias Hereditary aortic syndromes Hereditary arrhythmic syndromes Risk score
Received: July 28, 2025; Revised: July 28, 2025; Accepted: August 1, 2025; Published: October 6, 2025 Show citation
| ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Members ATF, (CPG) ECfPG, Societies ENC. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis 2019; 290: 140-205.
Go to original source...
Go to PubMed... - Arbelo E, Protonotarios A, Gimeno JR, et al. 2023 ESC Guidelines for the management of cardiomyopathies. European Heart Journal 2023; 44(37): 3503-626.
Go to original source...
Go to PubMed... - Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022; 43(40): 3997-4126.
Go to original source...
Go to PubMed... - Mazzolai L, Teixido-Tura G, Lanzi S, et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J 2024; 45(36): 3538-700.
Go to original source...
Go to PubMed... - Elliott P, Schunkert H, Bondue A, et al. Integration of genetic testing into diagnostic pathways for cardiomyopathies: a clinical consensus statement by the ESC Council on Cardiovascular Genomics. Eur Heart J 2025; 46(4): 344-53.
Go to original source...
Go to PubMed... - Stiles MK, Wilde AA, Abrams DJ, et al. 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families. Heart Rhythm 2021; 18(1): e1-e50.
Go to original source...
Go to PubMed... - Demolder A, Bianco L, Caruana M, et al. Arrhythmia and impaired myocardial function in heritable thoracic aortic disease: An international retrospective cohort study. European Journal of Medical Genetics 2022; 65(6): 104503.
Go to original source...
Go to PubMed... - Sabbag A, Essayagh B, Barrera JDR, et al. EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm. EP Europace 2022; 24(12): 1981-2003.
Go to original source...
Go to PubMed... - Giudicessi JR, Rohatgi RK, Bos JM, Ackerman MJ. Prevalence and clinical phenotype of concomitant long QT syndrome and arrhythmogenic bileaflet mitral valve prolapse. Int J Cardiol 2019; 274: 175-8.
Go to original source...
Go to PubMed... - Nordestgaard BG, Chapman MJ, Humphries SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 2013; 34(45): 3478-90a.
Go to original source...
Go to PubMed... - Cuchel M, Raal FJ, Hegele RA, et al. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance. Eur Heart J 2023; 44(25): 2277-91.
Go to original source...
Go to PubMed... - Isbister JC, Nowak N, Butters A, et al. "Concealed cardiomyopathy" as a cause of previously unexplained sudden cardiac arrest. International Journal of Cardiology 2021; 324: 96-101.
Go to original source...
Go to PubMed... - Wilde AAM, Semsarian C, Márquez MF, et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases. Heart Rhythm 2022; 19(7): e1-e60.
Go to original source...
Go to PubMed... - Basso C, Burke M, Fornes P, et al. Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch 2008; 452(1): 11-8.
Go to original source...
Go to PubMed... - Zeman M, Kučerová Š, Vojtíšek T, Hejna P. Standard autopsy and diagnostic procedure in forensic departments in cases of sudden cardiac death (SCD) in individuals under 40 years of age. Soud Lek 2023; 68(1): 2-10.
- Bonaventura J, Norambuena P, Tomašov P, et al. The utility of the Mayo Score for predicting the yield of genetic testing in patients with hypertrophic cardiomyopathy. Arch Med Sci 2019; 15(3): 641-9.
Go to original source...
Go to PubMed... - Bos JM, Will ML, Gersh BJ, Kruisselbrink TM, Ommen SR, Ackerman MJ. Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy. Mayo Clin Proc 2014; 89(6): 727-37.
Go to original source...
Go to PubMed... - Escobar-Lopez L, Ochoa JP, Royuela A, et al. Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy. J Am Coll Cardiol 2022; 80(12): 1115-26.
Go to original source...
Go to PubMed... - The Marfan Foundation. www.marfan.org.
- Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010; 47(7): 476-85.
Go to original source...
Go to PubMed... - Sheppard MN, van der Wal AC, Banner J, et al. Genetically determined cardiomyopathies at autopsy: the pivotal role of the pathologist in establishing the diagnosis and guiding family screening. Virchows Arch 2023; 482(4): 653-69.
Go to original source...
Go to PubMed... - Clinical Genome Resource. clinicalgenome.org.
- Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in medicine 2015; 17(5): 405-23.
Go to original source...
Go to PubMed... - Salfati EL, Spencer EG, Topol SE, et al. Re-analysis of whole-exome sequencing data uncovers novel diagnostic variants and improves molecular diagnostic yields for sudden death and idiopathic diseases. Genome Med 2019; 11(1): 83.
Go to original source...
Go to PubMed... - Campuzano O, Sarquella-Brugada G, Fernandez-Falgueras A, et al. Reanalysis and reclassification of rare genetic variants associated with inherited arrhythmogenic syndromes. EBioMedicine 2020; 54: 102732.
Go to original source...
Go to PubMed... - Quiat D, Witkowski L, Zouk H, Daly KP, Roberts AE. Retrospective Analysis of Clinical Genetic Testing in Pediatric Primary Dilated Cardiomyopathy: Testing Outcomes and the Effects of Variant Reclassification. J Am Heart Assoc 2020; 9(11): e016195.
Go to original source...
Go to PubMed... - Cabrera-Romero E, Ochoa JP, Barriales-Villa R, et al. Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives. J Am Coll Cardiol 2024; 83(17): 1640-51.
Go to original source...
Go to PubMed... - Kubanek M, Binova J, Piherova L, et al. Genotype is associated with left ventricular reverse remodelling and early events in recent-onset dilated cardiomyopathy. ESC Heart Fail 2024; 11(6): 4127-38.
Go to original source...
Go to PubMed... - Mazzanti A, Trancuccio A, Kukavica D, et al. Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk). Europace 2022; 24(4): 614-9.
Go to original source...
Go to PubMed... - Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 2010; 121(13): 1533-41.
Go to original source...
Go to PubMed... - O'Mahony C, Jichi F, Pavlou M, et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J 2014; 35(30): 2010-20.
Go to original source...
Go to PubMed... - Bonaventura J, Rowin EJ, Chan RH, et al. Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy. J Am Heart Assoc 2024; 13(10): e033565.
Go to original source...
Go to PubMed... - Honarbakhsh S, Providencia R, Garcia-Hernandez J, et al. A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK). JACC Clin Electrophysiol 2021; 7(2): 210-22.
Go to original source...
Go to PubMed... - Fellmann F, Van El CG, Charron P, et al. European recommendations integrating genetic testing into multidisciplinary management of sudden cardiac death. European Journal of Human Genetics 2019; 27(12): 1763-73.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.




